Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Current methods can't fully recreate skin and its features, and more research is needed for clinical use.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

Mechanical stimulation and new therapies show promise for hair regrowth.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

New treatments for skin damage from UV light using stem cells and their secretions show promise for skin repair without major risks.

Exosome therapy could be a promising new way to treat hair loss.

Edar signaling is crucial for proper hair follicle development and function.

Hair organoids are effective for testing hair loss treatments.

Hair follicle stem cells use specific chromatin changes to control their growth and differentiation.

Both cell and non-cell parts are important for rat whisker follicle regrowth.

New hair loss treatments like stem cells and gene therapy show promise but need more research for safety and effectiveness.

Exosomes can help promote hair growth and may treat hair loss.

Adding insulin-like growth factor 1 and bone marrow-derived stem cells to a collagen-chitosan scaffold helps wounds heal faster and regrows hair follicles.

Human hair follicle cells can grow hair when put into mouse skin if they stay in contact with mouse cells.

Engineered extracellular vesicles can improve tissue repair and regeneration.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

The mTurq2-Col4a1 mouse model shows that cells can divide while attached to stable basement membranes during development.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The skin's immune system helps it regenerate and fight infections.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

Exosomes could be key in treating skin conditions and healing wounds.

Engineered skin can grow chimeric hair follicles only with mouse dermal papilla cells.

Integumentary organs adapt and evolve for survival, with potential uses in regenerative medicine.

CD34 is a marker for isolating stem-like cells in mouse hair follicles.

Four transcription factors can convert mouse cells into hair cell-like cells, aiding hearing loss research and treatment.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.